Advances in Neurology: Treatment of Parkinsonism—The Role of Dopa Decarboxylase Inhibitors.

Darrell S. Buchanan, MC
Arch Intern Med. 1974;134(1):191. doi:10.1001/archinte.1974.00320190193065.
Text Size: A A A
Published online


This second volume contains 16 reports that were the major presentations of a conference on Parkinson disease held on Nov 28,1972. This conference was jointly sponsored by the Parkinson's Disease Foundation and Merck Sharp and Dohme Research Laboratories. The editor and publisher have done an extraordinary job of getting the book on the market while the information is still new.

The contributors constitute a virtual "Who's Who of basic and clinical research" related to the biochemistry and pharmacology of parkinsonism and can be accepted as highly authoritative sources in their respective areas. The 277 pages of text are quite varied with respect to the degree of sophistication required of the reader but, in general, those reports with prospective clinical application are easily comprehended. The general conclusion is that dopa decarboxylase inhibitors offer a worthwhile addition to the clinician's armamentarium and provide the researcher with a tool for further disecting


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.